Eterna Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.070
+0.030 (2.88%)
At close: Nov 4, 2024, 4:00 PM
1.120
+0.050 (4.66%)
After-hours: Nov 4, 2024, 4:02 PM EST
Eterna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6 | 10 | 17 | 217 | - | - | |
| Market Cap Growth | -16.87% | -41.17% | -92.39% | - | - | - | |
| Enterprise Value | 52 | 45 | 6 | 196 | - | - | |
| Last Close Price | 1.04 | 1.79 | 3.22 | 83.40 | - | - | |
| PE Ratio | - | -0.44 | -0.40 | -1.47 | - | - | |
| PS Ratio | 34.74 | 142.82 | - | - | - | - | |
| PB Ratio | -1.16 | 4.35 | 1.36 | 8.51 | - | - | |
| P/FCF Ratio | -0.59 | -0.48 | -0.78 | -9.18 | - | - | |
| P/OCF Ratio | -0.60 | -0.48 | -0.79 | -9.24 | - | - | |
| EV/Sales Ratio | 322.51 | 658.24 | - | - | - | - | |
| EV/EBITDA Ratio | -2.39 | -2.17 | -0.22 | -7.17 | - | - | |
| EV/EBIT Ratio | -2.38 | -2.16 | -0.22 | -7.14 | - | - | |
| EV/FCF Ratio | -3.10 | -2.19 | -0.28 | -8.28 | - | - | |
| Debt / Equity Ratio | -5.77 | 18.74 | 0.10 | 0.11 | 0.38 | 0.05 | |
| Debt / FCF Ratio | -2.92 | -2.05 | -0.06 | -0.12 | -0.36 | -0.05 | |
| Asset Turnover | 0.00 | 0.00 | - | - | - | - | |
| Quick Ratio | 0.29 | 1.22 | 1.62 | 4.81 | 0.52 | 1.16 | |
| Current Ratio | 0.37 | 1.46 | 1.79 | 5.10 | 0.55 | 1.18 | |
| Return on Equity (ROE) | - | -302.20% | -130.70% | -739.07% | -83.79% | -88.87% | |
| Return on Assets (ROA) | -29.41% | -36.19% | -63.26% | -77.17% | -32.34% | -34.96% | |
| Return on Capital (ROIC) | -34.49% | -45.05% | -81.98% | -88.41% | -43.53% | -52.75% | |
| Earnings Yield | -425.38% | -223.12% | -148.88% | -56.47% | - | - | |
| FCF Yield | -299.66% | -210.34% | -128.86% | -10.89% | - | - | |
| Buyback Yield / Dilution | -27.24% | -74.17% | -40.92% | -146.19% | - | - | |
| Total Shareholder Return | -27.24% | -74.17% | -40.92% | -146.19% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.